May 10, 2017 | Today’s News
Today's Top Story Study: One-third of newly approved drugs required FDA safety action. Nearly one-third of drugs approved by the U.S. Food and Drug Administration (FDA) from 2001 to 2010 had subsequent safety issues leading to some type of action by the FDA, researchers from Yale University reported in a study appearing in JAMA. The authors reported that of 222 novel therapeutics approved in those years, 71 warranted a postmarket safety event, with three of the drugs withdrawn [...]